Vanguard Group Inc. Trims Stock Position in Krystal Biotech, Inc. $KRYS
Vanguard Group Inc. reduced its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,778,845 shares of the company's stock after se...